Novo Nordisk A/S

NONOF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$15,655$14,392$12,653$10,720
Short-Term Investments$10,653$15,838$10,921$6,765
Receivables$87,414$75,261$57,505$46,799
Inventory$40,849$31,811$24,388$19,621
Other Curr. Assets$6,326$2,344$2,727$1,690
Total Curr. Assets$160,897$139,646$108,194$85,595
Property Plant & Equip (Net)$162,488$90,961$66,671$55,362
Goodwill$20,064$4,464$4,615$4,346
Intangibles$91,026$55,942$46,324$38,825
Long-Term Investments$2,677$1,663$1,343$1,441
Tax Assets$24,627$20,380$13,427$8,672
Other NC Assets$4,016$1,430$206$267
Total NC Assets$304,898$174,840$133,063$108,913
Other Assets$0$0$0$0
Total Assets$465,795$314,486$241,257$194,508
Liabilities
Payables$28,846$25,606$15,587$8,870
Short-Term Debt$13,113$6,478$1,466$13,684
Tax Payable$9,716$7,116$7,091$3,658
Deferred Revenue$0$0$0$55,178
Other Curr. Liab.$165,853$137,571$103,887-$37,052
Total Curr. Liab.$217,528$169,655$120,940$99,516
LT Debt$89,674$20,528$24,318$12,961
Deferred Rev, NC$0$0$0$5,654
Deferred Tax Liab, NC$5,426$10,162$7,061$5,271
Other NC Liab.$9,681$7,580$5,452$360
Total NC Liab.$104,781$38,270$36,831$24,246
Other Liabilities$0$0$0$0
Cap. Leases$6,766$5,726$4,529$4,129
Total Liabilities$322,309$207,925$157,771$123,762
Equity
Pref Stock$0$0$0$0
Common Stock$446$451$456$462
Retained Earnings$144,448$104,839$80,587$72,004
AOCI-$1,406$1,276$2,449-$1,714
Other Equity-$2-$5-$6-$6
Total Equity$143,486$106,561$83,486$70,746
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$465,795$314,486$241,257$194,508
Net Debt$87,132$12,614$13,131$15,925
Novo Nordisk A/S (NONOF) Financial Statements & Key Stats | AlphaPilot